Free Trial

Elanco Animal Health (ELAN) Earnings Date, Estimates & Call Transcripts

$15.09
-0.26 (-1.69%)
(As of 09/6/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Nov. 5Estimated
Actual EPS
(Aug. 8)
$0.30 Beat By $0.06
Consensus EPS
(Aug. 8)
$0.24
Skip Charts & View Estimated and Actual Earnings Data

ELAN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELAN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Elanco Animal Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.26$0.26$0.260.250 - 0.280
Q2 20241$0.24$0.24$0.240.230 - 0.260
Q3 20241$0.11$0.11$0.110.090 - 0.140
Q4 20241$0.17$0.17$0.17 
FY 20244$0.78$0.78$0.78 
Q1 20251$0.35$0.35$0.35 
Q2 20251$0.32$0.32$0.32 
Q3 20251$0.16$0.16$0.16 
Q4 20251$0.20$0.20$0.20 
FY 20254$1.03$1.03 $1.03

ELAN Earnings Date and Information

Elanco Animal Health last issued its quarterly earnings results on August 8th, 2024. The reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.06. The firm earned $1.18 billion during the quarter, compared to analyst estimates of $1.15 billion. Its quarterly revenue was up 12.0% on a year-over-year basis. Elanco Animal Health has generated ($2.65) earnings per share over the last year (($2.65) diluted earnings per share). Earnings for Elanco Animal Health are expected to grow by 10.99% in the coming year, from $0.91 to $1.01 per share. Elanco Animal Health has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off prior year's report dates.

Elanco Animal Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/5/2024
(Estimated)
------- 
8/8/2024Q2 2024$0.24$0.30+$0.06$0.70$1.15 billion$1.18 billion      
5/8/2024Q1 2024$0.26$0.34+$0.08$0.62$1.18 billion$1.21 billion    
2/26/2024Q4 2023$0.10$0.08($0.02)$0.45$1.00 billion$1.04 billion      
11/7/2023Q3 2023$0.12$0.18+$0.06$2.58$1.04 billion$1.07 billion      
8/7/2023Q2 2023$0.05$0.18+$0.13$0.56$1.04 billion$1.06 billion    
5/9/2023Q1 2023$0.29$0.45+$0.16$0.69$1.18 billion$1.26 billion      
2/21/2023Q4 2022$0.13$0.19+$0.06$0.49$980.94 million$988.00 million    
11/8/2022Q3 2022$0.16$0.20+$0.04$0.50$1.03 billion$1.03 billion
8/8/2022Q2 2022$0.26$0.36+$0.10$0.76$1.18 billion$1.18 billion      
5/9/2022Q1 2022$0.35$0.36+$0.01$0.62$1.22 billion$1.23 billion      
2/24/2022Q4 2021$0.17$0.21+$0.04$0.62$1.10 billion$1.11 billion    
11/5/2021Q3 2021$0.17$0.19+$0.02$0.59$1.08 billion$1.13 billion    
8/8/2021Q2 2021$0.26$0.28+$0.02$0.99$1.24 billion$1.28 billion    
5/6/2021Q1 2021$0.23$0.37+$0.14$0.86$1.16 billion$1.24 billion  
2/23/2021Q4 2020$0.09$0.12+$0.03$0.90$1.05 billion$1.14 billion  
11/6/2020Q3 2020$0.12$0.13+$0.01$0.55$922.48 million$889.60 million  
7/30/2020Q2 2020$0.02$0.09+$0.07$0.31$555.84 million$586.30 million  
5/7/2020Q1 2020$0.24$0.13($0.11)$0.38$720.19 million$657.70 million  
2/19/2020Q4 2019$0.23$0.23-$0.49$790.83 million$787.00 million  
11/6/2019Q3 2019$0.26$0.30+$0.04$0.57$765.85 million$771.30 million  

Elanco Animal Health Earnings - Frequently Asked Questions

When is Elanco Animal Health's earnings date?

Elanco Animal Health has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates. Learn more on ELAN's earnings history.

What guidance has Elanco Animal Health issued on next quarter's earnings?

Elanco Animal Health updated its third quarter 2024 earnings guidance on Thursday, August, 8th. The company provided EPS guidance of 0.090-0.140 for the period, compared to the consensus earnings per share estimate of 0.180. The company issued revenue guidance of $1.0 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Did Elanco Animal Health beat their earnings estimates last quarter?

In the previous quarter, Elanco Animal Health (NYSE:ELAN) reported $0.30 earnings per share (EPS) to beat the analysts' consensus estimate of $0.24 by $0.06. Learn more on analysts' earnings estimate vs. ELAN's actual earnings.

How can I listen to Elanco Animal Health's earnings conference call?

The conference call for Elanco Animal Health's latest earnings report can be listened to online. Listen to Conference Call

How can I read Elanco Animal Health's conference call transcript?

The conference call transcript for Elanco Animal Health's latest earnings report can be read online. Read Transcript

How can I view Elanco Animal Health's earnings report?

Elanco Animal Health's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Elanco Animal Health generate each year?

Elanco Animal Health (NYSE:ELAN) has a recorded annual revenue of $4.49 billion.

How much profit does Elanco Animal Health generate each year?

Elanco Animal Health (NYSE:ELAN) has a recorded net income of -$1.23 billion. ELAN has generated -$2.65 earnings per share over the last four quarters.

What is Elanco Animal Health's price-to-earnings ratio?

Elanco Animal Health (NYSE:ELAN) has a forward price-to-earnings ratio of 16.58. The price/earnings-to-growth ratio is 1.54.

What is Elanco Animal Health's EPS forecast for next year?

Elanco Animal Health's earnings are expected to grow from $0.91 per share to $1.01 per share in the next year, which is a 10.99% increase.


More Earnings Resources from MarketBeat

This page (NYSE:ELAN) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners